Lowe Brockenbrough & Co’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.13M Sell
30,801
-450
-1% -$31.1K 0.12% 122
2025
Q1
$2.21M Buy
+31,251
New +$2.21M 0.15% 118
2024
Q4
Sell
-32,782
Closed -$3.9M 266
2024
Q3
$3.9M Sell
32,782
-468
-1% -$55.7K 0.25% 93
2024
Q2
$4.75M Sell
33,250
-1,130
-3% -$161K 0.32% 79
2024
Q1
$4.45M Sell
34,380
-3,216
-9% -$416K 0.3% 87
2023
Q4
$3.89M Buy
37,596
+1,543
+4% +$160K 0.3% 87
2023
Q3
$3.28M Sell
36,053
-1,559
-4% -$142K 0.25% 99
2023
Q2
$3.04M Sell
37,612
-198
-0.5% -$16K 0.23% 99
2023
Q1
$3.03M Sell
37,810
-360
-0.9% -$28.9K 0.25% 97
2022
Q4
$2.58M Sell
38,170
-772
-2% -$52.2K 0.22% 102
2022
Q3
$1.94M Sell
38,942
-462
-1% -$23K 0.19% 122
2022
Q2
$2.2M Sell
39,404
-3,770
-9% -$210K 0.19% 116
2022
Q1
$2.42M Sell
43,174
-1,220
-3% -$68.4K 0.18% 118
2021
Q4
$2.49M Sell
44,394
-1,000
-2% -$56K 0.18% 109
2021
Q3
$2.18M Buy
45,394
+140
+0.3% +$6.72K 0.17% 124
2021
Q2
$1.9M Buy
45,254
+178
+0.4% +$7.45K 0.17% 114
2021
Q1
$1.52M Sell
45,076
-300
-0.7% -$10.1K 0.15% 127
2020
Q4
$1.59M Sell
45,376
-1,410
-3% -$49.3K 0.17% 116
2020
Q3
$1.62M Sell
46,786
-400
-0.8% -$13.9K 0.2% 109
2020
Q2
$1.55M Sell
47,186
-1,500
-3% -$49.1K 0.21% 108
2020
Q1
$1.47M Sell
48,686
-650
-1% -$19.6K 0.24% 100
2019
Q4
$1.43M Hold
49,336
0.18% 124
2019
Q3
$1.28M Buy
49,336
+1,750
+4% +$45.2K 0.17% 128
2019
Q2
$1.21M Buy
47,586
+90
+0.2% +$2.3K 0.17% 128
2019
Q1
$1.24M Sell
47,496
-300
-0.6% -$7.85K 0.17% 127
2018
Q4
$1.1M Buy
+47,796
New +$1.1M 0.18% 119